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Welcome to the new journal Diagnostic Pathology [1]!
This journal will be an open access, online journal encom-
passing all aspects of surgical pathology, including classic
diagnostic pathology, prognosis-related diagnosis and
therapy-related findings. There will be a focus on the tech-
nological aspects of pathology, including molecular biol-
ogy techniques, morphometry aspects, communication
aspects, electronic education, and quality assurance. Our
primary aim, however, is to close the gap between these
different specialisations within the field of diagnostic
pathology. For this reason we also welcome articles from
related fields in medicine and biology.
Why a new pathology journal, and why in a solely elec-
tronic presentation?
One reason to start Diagnostic Pathology follows from the
statement: We want to publish submitted articles inde-
pendent of any restrictions arising from the conditions
imposed by regular print issues. Traditional print journals
need to adjust the number of published articles to the
available space. If space is a scarce resource, this may
mean rejecting submissions that should be published or
result in a long waiting time until publication. Alterna-
tively, if the number of submissions is low, the situation
may result in acceptance of articles that do not meet strin-
gent quality criteria. These outcomes are undesirable and
amount to non-scientific behavior. As an online journal
that publishes articles immediately on acceptance, with
no dictates from deadlines, issues and volumes, Diagnos-
tic Pathology is under no pressure to publish any article
that does not stand up to fair but strict peer review.
Our second motivation for launching is a response to
another basically unscientific practice that colleagues
loathe but often find forced to pursue. I am referring to
the common practice of submitting to the journal with the
highest available impact factor; if the article does not get
accepted, the journal with the next lower ranking will be
selected, and so on. What gets entirely ignored is the very
point of conducting science: the dissemination of knowl-
edge to anyone who is interested, be it as fellow research-
ers, patients, or in any other capacity. The practice
described above more often than not leads to publication
in journals that are inaccessible for many, if not the vast
majority of people who would like to have access.
Traditional journals offer restricted access to articles.
Often only the title, keywords, and abstract are available
for free. The download of the full article then requires a
payment by the requesting scientist or her/his institution.
As a consequence, many researchers read only the abstract
of the article they are interested in, rather than the full arti-
cle. This practice is even worse as several journals restrict
the abstract size of their articles to less than 300 words.
From the scientific point of view, a far better strategy is to
offer all readers unrestricted access to the full articles.
Diagnostic Pathology will accept any publication as long
as it is sound science and holds the potential for scientific
impact – which, with the exception of a few rare discover-
ies, is largely unpredictable anyway. We are convinced
that a very considerable number of research articles have
been rejected by 'high score' journals due to various non-
scientific reasons. The embedding of Diagnostic Pathology
into the World Wide Web and its free global accessibility
offers all published articles the judgment of the interested
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scientific community. Thus, the scientific value of an arti-
cle published in Diagnostic Pathology is subject to the
evaluation of the scientific community only.
To enable the journal to make all of its content open
access, Diagnostic Pathology will levy an article-processing
charge for each manuscript accepted after peer review
(payable on acceptance). However, there will be an initial
period without charges, and many colleagues will find
that their institutions or funding agencies will cover the
costs for them [2,3].
I can only encourage my colleagues to carefully weigh the
scientific and financial arguments and to submit articles
to Diagnostic Pathology as a new open access journal. We
will certainly do our best to ensure that both sides,
authors and the research community, will benefit from
this new and exciting scientific initiative.
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